公开(公告)号：US10894083B2

公开(公告)日：2021-01-19

申请号：US15546370

申请日：2016-01-20

Applicant: Pfizer Inc.

Inventor： Rebecca Lee Ingram ,  Sarah Elizabeth Weiser

IPC: A61K39/395 ,  C07K16/22

Abstract: The present invention relates to the field of pharmaceutical formulations of antibodies. Specifically, the present invention relates to a stable liquid antibody formulation and its pharmaceutical preparation and use. This invention is exemplified by an aqueous formulation of an anti-vascular endothelial growth factor (VEGF) antibody.

公开(公告)号：US20180000933A1

公开(公告)日：2018-01-04

申请号：US15546370

申请日：2016-01-20

Applicant: Pfizer Inc.

Inventor： Rebecca Lee Ingram ,  Sarah Elizabeth Weiser

IPC: A61K39/395 ,  C07K16/22 ,  A61K31/57

Abstract: The present invention relates to the field of pharmaceutical formulations of antibodies. Specifically, the present invention relates to a stable liquid antibody formulation and its pharmaceutical preparation and use. This invention is exemplified by an aqueous formulation of an anti-vascular endothelial growth factor (VEGF) antibody.